Advertisement
Advertisement

ALVO

ALVO logo

Alvotech Ordinary Shares

3.67
USD
Sponsored
+0.12
+3.38%
May 13, 16:00 UTC -4
Closed
exchange

Pre-Market

3.69

+0.02
+0.68%

Alvotech Ordinary Shares Profile

About

Alvotech Holdings S.A. is a biotech company. It focused solely on the development and manufacture of biosimilar medicines for patients worldwide. Alvotech Holdings S.A., formerly known as Oaktree Acquisition Corp. II, is based in REYKJAVIK, Iceland.

Info & Links

CEO

Robert Wessman

Headquarters

9, RUE DE BITBOURG
LUXEMBOURG, N4 L-1273, LUXEMBOURG

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.alvotech.com

Auditor

Deloitte ehf.

Share holders

8

Employees

1,026

Alvotech Ordinary Shares Statistics

Valuation Measures

Market Capitalization2

1.15B

Enterprise Value

2.28B

Enterprise Value/EBITDA(ttm)

121.00

Price to Earnings Ratio(ttm)

36.00

Price to Sales(ttm)

1.84

Price to Book(mrq)

--

Price to Cash(ytd)

16.52

Profitability

Gross Margin(ttm)

12.68%

Operating Margin(ttm)

4.74%

Profit Margin(ttm)

20.65%

Return on Equity(ttm)

-11.92%

Return on Invested Capital(ttm)

9.89%

Return on Assets(ttm)

2.02%

Income Statement

Revenue(ttm)

132.76M

Revenue Per Share(ttm)

0.43

Gross Profit(ttm)

67.32M

EBITDA(ttm)3

18.84M

Net Income Available to Common(ttm)

109.68M

Diluted EPS(ttm)

0.10

Share Statistics

Beta (5Y Monthly)

0.25

52-Week Change

-65.25%

S&P 500 52-Week Change

26.33%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

312.02M

Dividend Yield

0.00%

Float4

300.42M

% Held by Insiders

0.46%

% Held by Institutions

0.00%

Balance Sheet

Total Cash(mrq)

172.36M

Total Cash Per Share(mrq)

0.55

Total Debt(mrq)

1.30B

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

--

Quick Ratio(mrq)

1.16%

Book Value Per Share(mrq)

--

Cash Flow

Operating Cash Flow Per Share(ytd)

--

Free Cash Flow(ytd)

0.00

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement